Flu drug setback

日期:2019-03-07 08:08:17 作者:丁采最 阅读:

The flu treatment Relenza looks unlikely to be made available on the National Health Service in Britain. As New Scientist went to press, the National Institute for Clinical Excellence was thought to have advised against releasing the drug, which limits symptoms and hastens recovery. Richard Sykes, chairman of Glaxo Wellcome, the drug’s maker, is incensed. Yet a company data sheet prepared in August states that the drug has yet to be shown to work in chronically ill or immunocompromised patients,